YGEN.L Stock - Yourgene Health Plc
Unlock GoAI Insights for YGEN.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $37.56M | $18.29M | $16.61M | $8.88M | $6.15M |
| Gross Profit | $21.36M | $11.38M | $10.22M | $4.61M | $3.17M |
| Gross Margin | 56.9% | 62.2% | 61.5% | 51.9% | 51.6% |
| Operating Income | $-2,540,000 | $-11,708,939 | $-3,238,867 | $-4,782,506 | $-8,601,728 |
| Net Income | $-1,916,000 | $-12,183,632 | $-2,433,924 | $3.39M | $-9,482,927 |
| Net Margin | -5.1% | -66.6% | -14.7% | 38.2% | -154.3% |
| EPS | $-0.00 | $-0.02 | $-0.00 | $0.01 | $-0.03 |
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.
Visit WebsiteEarnings History & Surprises
YGEN.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Sep 28, 2023 | — | — | — | — |
Q3 2023 | Aug 29, 2023 | — | — | — | — |
Q3 2022 | Sep 30, 2022 | — | — | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.02 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q3 2019 | Sep 30, 2019 | — | $0.00 | — | — |
Q1 2019 | Mar 31, 2019 | — | $0.00 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.01 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.01 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.01 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.01 | — | — |
Q3 2016 | Sep 30, 2016 | — | $-0.01 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.01 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-0.01 | — | — |
Q1 2015 | Mar 31, 2015 | — | $-0.01 | — | — |
Q3 2014 | Sep 30, 2014 | — | $-0.06 | — | — |
Q1 2009 | Mar 31, 2009 | — | $-0.59 | — | — |
Q3 2008 | Sep 30, 2008 | — | $-0.59 | — | — |
Q1 2008 | Mar 31, 2008 | — | $-0.48 | — | — |
Latest News
Frequently Asked Questions about YGEN.L
What is YGEN.L's current stock price?
What is the analyst price target for YGEN.L?
What sector is Yourgene Health Plc in?
What is YGEN.L's market cap?
Does YGEN.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to YGEN.L for comparison